Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)-Reference-Cited by-同舟云学术

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Published:2016-01-06 Issue:6 Volume:57 Page:1256-1268
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bruno Benedetto,Auner Holger W.,Gahrton Gösta,Garderet Laurent,Festuccia Moreno,Ladetto Marco,Lemoli Roberto M.,Massaia Massimo,Morris Curly,Palumbo Antonio,Schönland Stefan,Boccadoro Mario,Kröger Nicolaus

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2015.1131278

Reference84 articles.

1. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

2. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

3. Age Is Not a Prognostic Variable With Autotransplants for Multiple Myeloma

4. A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

5. Autologous Transplantation and Maintenance Therapy in Multiple Myeloma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of multiple myeloma: A monoclonal plasma cell malignancy’s diagnosis, management, and treatment modalities;Saudi Journal of Biological Sciences;2024-02

2. Highly proliferative and functional PD-1+ and TIM-3+ T cells are transiently increased in multiple myeloma following autologous hematopoietic stem cell transplantation;International Immunopharmacology;2021-11

3. Higher efficacy of intermediate dose cytarabine + G‐CSF compared to cyclophosphamide + G‐CSF in hematopoietic stem cell mobilization in patients with multiple myeloma;Journal of Clinical Apheresis;2020-04-16

4. Increased Efficacy of Stem Cell Chemomobilization with Intermediate-Dose Cytarabine Plus Granulocyte Colony-Stimulating Factor (G-CSF) Compared with G-CSF Alone in Patients with Multiple Myeloma: Results of a Randomized Trial;Biology of Blood and Marrow Transplantation;2019-02

5. Melphalan 140 mg/m 2 or 200 mg/m 2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party;Haematologica;2017-12-07